Sgltr M 100Mg/1000Mg Tablet is an anti-diabetic medication used to treat type 2 diabetes mellitus in addition to diet and exercise. Type 2 diabetes is often referred to as non-insulin-dependent diabetes or adult-onset diabetes. It is a medical disorder characterized by elevated blood glucose levels caused by insulin insufficiency, insulin resistance, or both.

Usage instructions-

• The dose and duration of Sgltr M 100Mg/1000Mg Tablet should be taken as directed by your doctor. You can have Sgltr M 100Mg/1000Mg Tablet with food.

How it works-

Sgltr M 100Mg/1000Mg Tablet comprises the active drugs Remogliflozin etabonate and metformin. Remogliflozin etabonate aids in the removal of excess sugar from the body through the urine. Metformin inhibits sugar synthesis by liver cells and slows sugar absorption from the intestines. It also raises insulin sensitivity in the body. Sgltr M 100Mg/1000Mg Tablet works together to assist manage blood sugar levels.

Safety information-

Pregnancy

Sgltr M 100Mg/1000Mg Tablet is probably not safe to use in pregnancy. There are limited human studies, but animal studies have shown adverse effects on the developing baby. Consult your doctor.

Breastfeeding

It is probably not safe to breastfeed while taking Sgltr M 100Mg/1000Mg Tablet. There is limited human data suggesting that the drug may enter breast milk and cause harm to the baby.

Alcohol

It is unsafe to take alcohol with Sgltr M 100Mg/1000Mg Tablet.

Driving

If you have too high or too low blood sugar, it could affect your ability to drive. If you experience these symptoms, don't drive.

Kidney

Sgltr M 100Mg/1000Mg Tablet should be administered with caution to patients with kidney disease. Dose adjustments may be necessary. Please consult your doctor.

Liver

Sgltr M 100Mg/1000Mg Tablet should be avoided in those who have liver problems. Please consult your physician.